Chinese Journal of Natural Medicines(2025年08期)
中国天然药物(英文版)

目 录

• Advances in the study of pharmacotherapy for addiction to naturally-derived psychoactive substances
• Facilitating microglial phagocytosis by which Jiawei Xionggui Decoction alleviates cognitive impairment via TREM2-mediated energy metabolic reprogramming
• Design and synthesis of novel saponin-triazole derivatives in the regulation of adipogenesis
• (±)-Talapyrones A-F: six pairs of dimeric polyketide enantiomers with unusual 6/6/6 and 6/6/6/5 ring systems from Talaromyces adpressus
• Lirispirolides A-L, a new class of sesquiterpene-monoterpene heterodimers with anti-neuroinflammatory activity from the rare medicinal plant Liriodendron chinense
• New tetrahydroanthraquinones and γ-butenolides from the fungus Auxarthron umbrinum DSM3193
• Dimeric sesquiterpenoids with anti-inflammatory activities from Inula britannica
• Structurally novel tryptamine-derived alkaloids from the seeds of Peganum harmala and their antiviral activities against respiratory syncytial virus
• Diketopiperazines with anti-skin inflammation from marine-derived endophytic fungus Aspergillus sp. and configurational reassignment of aspertryptanthrins
• Ten new lignans with anti-inflammatory activities from the leaves of Illicium dunnianum
• The transcriptomic-based disease network reveals synergistic therapeutic effect of total alkaloids from Coptis chinensis and total ginsenosides from Panax ginseng on type 2 diabetes mellitus
• Profiling the chemical differences of diterpenoid alkaloids in different processed products of Aconiti Lateralis Radix Praeparata by UHPLC-LTQ-Orbitrap mass spectrometry combined with untargeted metabolomics and mass spectrometry imaging
• Combining label-free quantitative proteomics and 2D-DIGE to identify the potential targets of Sini Decoction acting on myocardial infarction